BERGMANN ANTHONY (Chief Financial Officer) sold 75.2% of their position (25K shares) of CAPRICOR THERAPEUTICS, INC. on the open market
Open‑market sale worth $792.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001593087-26-000007
Officer· Chief Financial Officer
Since Aug 2019
-25K
Net shares
Net seller
$792.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$3.18
Trade value
$79.50K
% of position
304.0%
5/1/2026
8.22K→33.22K
Common Stock
Direct
Shares
−25K
Price / share
$31.70
Trade value
$792.54K
% of position
75.2%
5/1/2026
33.22K→8.22K
Total
Net shares
+0.00
Net value
-$713.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +25K | $3.18 | $79.50K | 304.0% | 8.22K | 33.22K |
| Common Stock Direct | 5/1/2026 | S · Sale | −25K | $31.70 | $792.54K | 75.2% | 33.22K | 8.22K |
| Total | +0.00 | -$713.04K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
3.18
Held after
116.98K
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 5/1/2026 | M · Option Exercise | −25K | 3.18 | — | 116.98K |